Chargement en cours...
The adaptive stroma joining the antiangiogenic resistance front
Resistance to antiangiogenic therapies in cancer involves both tumor cells and stromal components, but their relative contributions differ in each cancer subtype. In this issue of the JCI, Cascone et al. describe a stromal adaptation to antiangiogenic therapy in non–small cell lung carcinoma (NSCLC)...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069791/ https://ncbi.nlm.nih.gov/pubmed/21436579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46430 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|